Antidepressant Drugs Plus Exposure Treatment of Agoraphobia/Panic and Obsessive-Compulsive Disorders

References

• Phobia, Psychological and Pharmacological Treatment, M. Mavissakalian, D. H. Barlow. The Guilford Press, New York 1981
   Google Scholar
• Obsessive-Compulsive Disorder: Psychological and Pharmacological Treatment, M. Mavissakalian, S. M. Turner, L. Michelson. Plenum Press, New York 1985
   Google Scholar
• Marks I. M. Fears, Phobias and Rituals. Oxford University Press, New York 1987
   Google Scholar
• Michelson L., Mavissakalian M., Marchione K. Cognitive behavioral and psychophysiological treatments of agoraphobia: a comparative outcome investigation. Behavior Therapy 1988; 19: 97–120
   Web of Science ®Google Scholar
• Foa E. B., Steketee G. S., Ozarow B. J. Behavior therapy with obsessive-compulsives: from theory to treatment. Obsessive-Compulsive Disorder: Psychological and Pharmacological Treatment, M. Mavissakalian, S. M. Turner, L. Michelson. Plenum Press, New York 1985
   Google Scholar
• Lydiard R. B., Roy-Byrne P. P., Ballenger J. C. Recent advances in the psychopharmacological treatment of anxiety disorders. Hospital and Community Psychiatry 1988; 39: 1157–1165
   PubMedGoogle Scholar
• Mavissakalian M. Sequential combination of imipramine and behavioral instructions in the treatment of panic disorder with agoraphobia. Journal of Clinical Psychiatry 1989, in press
   Web of Science ®Google Scholar
• Mavissakalian M., et al. Clomipramine in obsessive-compulsive disorder. 1989, submitted for publication
   Google Scholar
• Zitrin C. M., Klein D. F., Woerner M. C. Treatment of agoraphobia with group exposure in vivo and imipramine. Archives of General Psychiatry 1980; 37: 63
   PubMed Web of Science ®Google Scholar
• Zitrin C. M., Klein D. F., Woerner M. G. Treatment of phobias I. Comparison of imipramine hydrochloride and placebo. Archives of General Psychiatry 1983; 40: 125
   PubMed Web of Science ®Google Scholar
• Marks I. M., Gray S., Cohen D., Hill R., Mawson D., Ramm E., Stern R. S. Imipramine and brief therapist aided exposure in agoraphobics having self-exposure homework. Archives of General Psychiatry 1983; 40: 153
   PubMed Web of Science ®Google Scholar
• Mavissakalian M., Michelson L., Dealy R. S. Pharmacological treatment of agoraphobia: imipramine vs imipramine with programmed practice. British Journal of Psychiatry 1983; 143: 348
   PubMed Web of Science ®Google Scholar
• Telch M. J., Agras W. S., Taylor C. B., Roth W. T., Gallen C. C. Combined pharmacological and behavioral treatment for agoraphobia. Behavior Research Therapy 1985; 23: 325
   PubMed Web of Science ®Google Scholar
• Mavissakalian M., Michelson L. Relative and combined effectiveness of therapist-assisted in vivo exposure and imipramine. Journal of Clinical Psychiatry 1986; 47: 117–122
   PubMed Web of Science ®Google Scholar
• Marks I. M., Stern R. S., Mawson D., Cobb J., McDonald R. Clomipramine and exposure for obsessive-compulsive rituals: I. British Journal of Psychiatry 1980; 136: 1–25
   PubMed Web of Science ®Google Scholar
• Marks I. M., Lelliot P., Basoglu M., Noshirvani H., Monteiro W., Cohen D., Kasvikis Y. Clomipramine, self-exposure and therapistaided exposure for obsessive-compulsive rituals. British Journal of Psychiatry 1988; 152: 522–534
   PubMed Web of Science ®Google Scholar
• Mavissakalian M. Exposure treatment of agoraphobia. Psychiatry Update, L. Grinspoon. American Psychiatric Press, Washington, DC 1984; Vol. 3
   Google Scholar
• Ghosh A., Marks I. M. Self-treatment of agoraphobia by exposure. Behavior Therapy 1987; 18: 3–16
   Web of Science ®Google Scholar
• Cohen S. D., Monteiro W., Marks I. M. Two-year follow-up of agoraphobics after exposure and imipramine. British Journal of Psychiatry 1984; 144: 276–281
   PubMed Web of Science ®Google Scholar
• Mavissakalian M., Michelson L. Two-year follow-up of exposure and imipramine treatment of agoraphobia. American Journal of Psychiatry 1986; 143: 1106–1112
   PubMed Web of Science ®Google Scholar
• Mavissakalian M., Perel J. M. Imipramine dose-response relationship in panic disorder with agoraphobia. Archives of General Psychiatry 1989; 46: 127–131
   PubMed Web of Science ®Google Scholar
• Mawson D., Marks I. M., Ramm L. Clomipramine and exposure for chronic obsessive-compulsive rituals: III. Two year follow-up and further findings. British Journal of Psychiatry 1982; 140: 11–18
   PubMed Web of Science ®Google Scholar
• Benkelfat C., Murphy D. L., Zohar J., Hill J. K., Grover G., Insel T. R. Clomipramine in obsessive-compulsive disorder. Archives of General Psychiatry 1989; 46: 23–28
   PubMed Web of Science ®Google Scholar
• Westenberg H., Den Boer J. A. Serotonin-influencing drugs in the treatment of panic disorder. Psychopathology 1989; 22(suppl 1)68–77
   PubMedGoogle Scholar
• Goodman W. K., Price L. H., Rasmussen S. A., Delgado P. L., Heninger G. R., Charney D. S. Efficacy of fluvoxarmne in obsessive-compulsive disorder. Archives of General Psychiatry 1989; 46: 36–44
   PubMed Web of Science ®Google Scholar
• Mavissakalian M., Turner S. M., Michelson L., Jacob R. Tricyclic antidepressants in obsessive-compulsive disorder: antiobessional or antidepressant agents? II. American Journal of Psychiatry 1985; 142(5)572–576
   PubMed Web of Science ®Google Scholar
• Mavissakalian M. Initial depression and response to imipramine in agoraphobia. Journal of Nervous and Mental Disease 1987; 175(6)358–361
   PubMed Web of Science ®Google Scholar
• Zohar J., Insel T. R. Drug treatment of obsessive-compulsive disorder. Journal of Affective Disorders 1987; 13: 193–202
   PubMed Web of Science ®Google Scholar
• Den Boer J. A., Westenberg H. G. M. Effect of serotonin and noradrenaline uptake inhibitor in panic disorder; a double-blind comparative study with fluvoxamine and maprotiline. International Clinical Psychopharmacology 1988; 3: 59–74
   PubMed Web of Science ®Google Scholar
• Sheehan D. V., Davidson J., Manschreck T., Van Wyck, Fleet J. Lack of efficacy of a new antidepressant (bupropion) in the treatment of panic disorder with phobias. Journal of Clinical Psychopharmacology 1983; 3: 28–31
   PubMed Web of Science ®Google Scholar
• Mavissakalian M., Michelson L. Self-directed in vivo exposure practice in behavioral and pharmacological treatments of agoraphobia. Behavior Therapy 1983; 14: 506–519
   Web of Science ®Google Scholar
• Mavissakalian M. The placebo effect in agoraphobia-II. Journal of Nervous and Mental Disease 1988; 176: 446–448
   PubMed Web of Science ®Google Scholar
• Coryell W., Noyes R. Placebo response in panic disorder. American Journal of Psychiatry 1988; 145(9)1138–1140
   PubMed Web of Science ®Google Scholar
• Mavissakalian M., Jones B., Olson S. Absence of placebo response in obsessive-compulsive disorder. Journal of Nervous and Mental Disease 1989, in press
   Web of Science ®Google Scholar